Virenix Overview
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Virenix General Information
Description
Developer of antiviral drugs for diseases designed to improve treatments for viral diseases. The company offers research support for antiviral drug discovery, access to a catalog of viral proteins, software for crystallography and protein expression, and services for screening viral proteins and viruses, enabling clients to accelerate drug discovery processes, access specialized resources for research, and develop treatments efficiently.
Contact Information
Website
www.virenix.comCorporate Office
- South Africa
Corporate Office
- South Africa
Virenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 30-Dec-2024 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Startup |
Virenix FAQs
-
Where is Virenix headquartered?
Virenix is headquartered in South Africa.
-
What industry is Virenix in?
Virenix’s primary industry is Other Commercial Services.
-
Is Virenix a private or public company?
Virenix is a Private company.
-
What is Virenix’s current revenue?
The current revenue for Virenix is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process